How to prevent, recognize, and treat drug-induced nephrotoxicity

Cleveland Clinic Journal of Medicine

Volumn 69, Issue 4, 2002, Pages 289-312

  Guo, Xiaoqing ^a   Nzerue, Chike ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; CAPTOPRIL; CEPHALOSPORIN; CISPLATIN; COCAINE; CONTRAST MEDIUM; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FENOPROFEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN; INTERLEUKIN 2; LITHIUM; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PENICILLIN G; PENTAMIDINE; PHENYTOIN; PREDNISONE; RANITIDINE; SODIUM CHLORIDE; STREPTOKINASE; SULFONAMIDE; TACROLIMUS; UNINDEXED DRUG; VALPROIC ACID;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ARTICLE; CHRONIC KIDNEY FAILURE; DRUG EXPOSURE; DRUG USE; HUMAN; IMMUNE COMPLEX NEPHRITIS; INTERSTITIAL NEPHRITIS; KIDNEY INJURY; NEPHROTIC SYNDROME; NEPHROTOXICITY; RISK FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0036230206     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.69.4.289     Document Type: Article

References (76)

1. The cellular basis of nephrotoxicity
2. Pathogenetic mechanisms in nephrotoxic acute renal failure
3. A role for calcium in radiocontrast-induced reductions in renal hemodynamics
4. Radiocontrast increases plasma and urinary endothelin
5. Nephrotoxic risks of renal angiography: Contrast media-associated nephrotoxicity and atheroembolism-a critical review
6. Inhibitory effects of gentamicin on renal cortical mitochondrial oxidative phosphorylation
7. Platinum nephrotoxicity
8. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality
9. Epidemiology of acute renal failure: A prospective, multicenter, community-based study
10. Renal insufficiency after intravenous immunoglobulin therapy: A report of two cases and analysis of literature
11. Polyethylene glycol nephrotoxicity secondary to prolonged high-dose intravenous lorazepam
12. Acute tubulointerstitial nephritis
13. Pathogenesis and therapy of interstitial nephritis
14. Eosinophiluria - A new method of detection and definition of the clinical spectrum
15. [A case of Chinese herbs nephropathy in which the progression of renal dysfunction was slowed by steroid therapy.]
16. The hemolytic uremic syndrome
17. Cyclosporine and tacrolimus associated thrombotic microangiopathy
18. Renal toxicities of antineoplastic drugs and bone marrow transplantation
19. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura
20. Cocaine-induced acute renal failure, hemolysis and thrombocytopenia mimicking thrombotic thrombocytopenic purpura
21. Cancer and chemotherapy-associated thrombotic microangiopathy
22. Crystal-induced acute renal failure
23. Symptomatic sulfadiazine crystalluria in AIDS patients: A report of two cases
24. Indinavir crystallization and urolithiasis
25. Acute renal failure due to oral acyclovir in a man with sickle cell trait
26. Acute renal failure and neurotoxicity following oral acyclovir
27. Acyclovir-induced renal failure. Clinical course and histology
28. Light microscopy of indinavir urinary crystals
29. Acute renal failure, oxalosis, and vitamin C supplementation: A case report and review of the literature
30. Guaifenesin- and ephedrine-induced stones
31. Chronic interstitial nephritis due to 5-aminosalicylic acid
32. Calcineurin inhibitors in renal transplantation. Too precious to be abandoned
33. Are COX-2 selective inhibitors nephrotoxic?
34. NSAIDs and the kidney revisited: Are selective cyclooxygenase-2 inhibitors safe?
35. Ibuprofen-associated renal impairment in a large general medicine practice
36. Nonsteroidal anti-inflammatory drug-associated azotemia in the very old
37. The effect of nonsteroidal antiinflammatory drugs on electrolyte homeostasis and blood pressure in young and elderly persons with and without renal insufficiency
38. Ketorolac induced acute renal failure following a single dose
39. Acute nonoliguric renal failure in children associated with nonsteroidal anti-inflammatory agents
40. Nonsteroidal anti-inflammatory drugs and the kidney
41. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: Physiologic foundations and clinical implications
42. COX-2 inhibitors and acute renal failure
43. Renal effects of over-the-counter analgesics
44. Acute renal failure due to acetaminophen ingestion: A case report and review of the literature
45. Fatal hepatitis and renal failure during treatment with nimesulide
46. Drug-induced renal disease
47. High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure
48. Aminoglycoside nephrotoxicity
49. Single or multiple daily doses of aminoglycosides: A meta-analysis
50. The effect of dosing strategy on kidney cortical accumulation of aminoglycosides
51. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity
52. Captopril induced functional renal insufficiency in patients with bilateral renal artery stenosis, or stenosis in a solitary kidney
53. Renal failure limiting anti-hypertensive therapy as an indication for renal vascularization
54. Deterioration in renal function associated with angiotensin-converting enzyme inhibitor therapy is not always reversible
55. Renal failure related to angiotensin-converting enzyme inhibitors
56. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: Is this a cause for concern?
57. Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: Results of a double-blind, randomized comparative trial
58. The benefits of angiotensin II receptor blockers in patients with renal insufficiency or failure
59. Are drugs that block the renin-angiotensin system effective in and safe in patients with renal insufficiency?
60. [Different effect of angiotensin converting enzyme inhibitors and AT1 receptor blockers on renal function in patients with chronic renal failure.]
61. [Successful use of angiotensin II receptor (Iosartan) antagonist in a patient with sclerodermal renal crisis.]
62. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study
63. Clinical significance of nephrotoxicity associated with amphotericin B for suspected or proven aspergillosis
64. Prevention of amphotericin B-induced renal impairment: A review on the use of sodium supplementation
65. Amphotericin B nephrotoxicity: The adverse consequences of altered membrane properties
66. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia
67. Nephropathy and herbal medicine
68. Acute renal failure among blacks and Indians in South Africa
69. Acute renal failure from herbal and patent remedies in Blacks
70. Traditional herbal preparations and acute renal failure in south-West Nigeria
71. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs
72. Identification of aristolochic acid in Chinese herbs
73. Urothelial lesions in Chinese herbs nephropathy
74. Valvular heart disease and Chinese herb nephropathy
75. The myth of beneficent nature: The risks of herbal preparations
76. Cocaine and the kidney: A synthesis of pathophysiologic and clinical perspectives